REDUCE-IT: 25% Reduction in MACE With High-Dose EPA
High doses (4-g daily) of the omega-3 oil eicosapentaenoic acid (EPA) have shown a large benefit on cardiovascular events in the randomized, double-blind REDUCE-IT trial.
Latest news
Category: Health professionals
Raised Lp(a) Slashed in CV Patients on Novel Antisense Agent
Integration of child–parent screening and cascade testing for familial hypercholesterolaemia
This study explores integrate child–parent screening and cascade testing into a single pathway-child-parent cascade screening (CPCS), for the identification of familial hypercholesterolaemia in the population and to estimate the number of new familial hypercholesterolaemia cases identified per child screened and the associated costs.
Source: Journal of Medical Screening